Endomucin regulates vascular endothelial growth factor (VEGF) Receptor 2 (VEGFR2) Endocytosis

被引：0
作者：
LeBlanc, M. [1 ]
Hu, Z. [1 ]
Saez-Torres, K. [1 ]
Saint-Geniez, M. [1 ]
Ng, E. [1 ]
D'Amore, P. [1 ]
机构：
[1] Schepens Eye Res Inst Mass Eye & Ear, Boston, MA USA
来源：
AMERICAN JOURNAL OF PATHOLOGY | 2018年 / 188卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
CIRSP5
引用
收藏
页码：2420 / 2421
页数：2
相关论文
共 50 条
  • [21] Screening of the transcriptional regulatory regions of vascular endothelial growth factor receptor 2 (VEGFR2) in amyotrophic lateral sclerosis
    Brockington, Alice
    Wokke, Beatrijs
    Nixon, Hannah
    Hartley, Judith
    Shaw, Pamela J.
    BMC MEDICAL GENETICS, 2007, 8
  • [22] Altered expression of vascular endothelial growth factor receptor 2 (VEGFR2) in the prefrontal cortex of the rat with neuropathic pain
    Cheppudira, B.
    Sosanya, N.
    Trevino, A.
    Christy, R.
    JOURNAL OF PAIN, 2017, 18 (04) : S19 - S19
  • [23] Vascular endothelial growth factor receptor 2 (VEGFR2) expression is reduced by hypoxia in the neonatal piglet pulmonary vasculature
    Baribeau, J
    Nadeau, S
    Janvier, A
    Perreault, T
    FASEB JOURNAL, 2003, 17 (04) : A421 - A422
  • [24] Angiogenesis and radiation response modulation after vascular endothelial growth factor receptor-2 (VEGFR2) blockade
    Li, J
    Huang, S
    Armstrong, EA
    Fowler, JF
    Harari, PM
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 62 (05): : 1477 - 1485
  • [25] Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) Blockade as New Therapeutic Opportunity for Polycystic Kidney Disease
    Nunez-Gonzalez, Laura
    Tejedor, Lucia
    Pereira Hernandez, Maria
    Barcia De la Iglesia Ana
    Cordido, Adrian
    Garcia-Gonzalez, Miguel A.
    Ruiz-Ortega, Marta
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [26] Short Report: Elevated Levels of Vascular Endothelial Growth Factor (VEGF) and Soluble Vascular Endothelial Growth Factor Receptor (VEGFR)-2 in Human Malaria
    Furuta, Takahisa
    Kimura, Mikio
    Watanabe, Naohiro
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2010, 82 (01) : 136 - 139
  • [27] Stylopine: A potential natural metabolite to activate vascular endothelial growth factor receptor 2 (VEGFR2) in osteosarcoma therapy
    Velayutham, Naveen Kumar
    Thamaraikani, Tamilanban
    Wahab, Shadma
    Khalid, Mohammad
    Ramachawolran, Gobinath
    Abullais, Shahabe Saquib
    Wong, Ling Shing
    Sekar, Mahendran
    Gan, Siew Hua
    Ebenezer, Angel Jemima
    Ravikumar, Mrinalini
    Subramaniyan, Vetriselvan
    Mat Rani, Nur Najihah Izzati
    Wu, Yuan Seng
    Jeyabalan, Srikanth
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [28] Involvement Of Vascular Endothelial Growth Factor Receptor 2 (VEGFR2) In Oxidized Phospholipid-Mediated Control Of Endothelial Barrier Function
    Zebda, N.
    Ho, T.
    Moldobaeva, N.
    Birukova, A.
    Berliner, J. A.
    Birukov, K. G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [29] Effects of silencing epididymal vascular endothelial growth factor (VEGF) expression on hyaluronidase (HYD) activity in arsenic poisoning rats through downregulating VEGF receptor 2 (VEGFR2)
    Dai, Yan-ping
    Gao, Xiao-qin
    BIOENGINEERED, 2021, 12 (01) : 1351 - 1359
  • [30] Procyanidin B2 inhibits angiogenesis and cell growth in oral squamous cell carcinoma cells through the vascular endothelial growth factor (VEGF)/VEGF receptor 2 (VEGFR2) pathway
    Sun, Qiurong
    Zhang, Taiyang
    Xiao, Qingchun
    Mei, Bingxin
    Zhang, Xingwang
    BIOENGINEERED, 2022, 13 (03) : 6500 - 6508
12345